Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J J van der Zande"'
Autor:
M. van de Beek, I. van Steenoven, J. J. van der Zande, I. Porcelijn, F. Barkhof, C. J. Stam, P. G. H. M. Raijmakers, P. Scheltens, C. E. Teunissen, W. M. van der Flier, A. W. Lemstra
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Abstract Background The DEmEntia with LEwy bOdies Project (DEvELOP) aims to phenotype patients with dementia with Lewy bodies (DLB) and study the symptoms and biomarkers over time. Here, we describe the design and baseline results of DEvELOP. We inve
Externí odkaz:
https://doaj.org/article/e791df94bbb647a99215326a9d382377
Autor:
Frederik Barkhof, J J van der Zande, I. van Steenoven, M. van de Beek, Charlotte E. Teunissen, P.G.H.M. Raijmakers, Philip Scheltens, W.M. van der Flier, Cornelis J. Stam, I Porcelijn, Afina W. Lemstra
Publikováno v:
Alzheimer's Research & Therapy, 13(1):53. BioMed Central
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
van de Beek, M, van Steenoven, I, van der Zande, J J, Porcelijn, I, Barkhof, F, Stam, C J, Raijmakers, P G H M, Scheltens, P, Teunissen, C E, van der Flier, W M & Lemstra, A W 2021, ' Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results ', Alzheimer's Research & Therapy, vol. 13, no. 1, 53, pp. 53 . https://doi.org/10.1186/s13195-021-00792-w
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
van de Beek, M, van Steenoven, I, van der Zande, J J, Porcelijn, I, Barkhof, F, Stam, C J, Raijmakers, P G H M, Scheltens, P, Teunissen, C E, van der Flier, W M & Lemstra, A W 2021, ' Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results ', Alzheimer's Research & Therapy, vol. 13, no. 1, 53, pp. 53 . https://doi.org/10.1186/s13195-021-00792-w
Background The DEmEntia with LEwy bOdies Project (DEvELOP) aims to phenotype patients with dementia with Lewy bodies (DLB) and study the symptoms and biomarkers over time. Here, we describe the design and baseline results of DEvELOP. We investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0346884e8da77baa52f152895f6526
https://research.vumc.nl/en/publications/83dc22f7-1503-448c-89fe-be92950658b9
https://research.vumc.nl/en/publications/83dc22f7-1503-448c-89fe-be92950658b9
Autor:
M. Van De Beek, I. Van Steenoven, J. J. Van Der Zande, I. Porcelijn, F. Barkhof, C. J. Stam, P. G. H. M. Raijmakers, P. Scheltens, C. E. Teunissen, W. M. Van Der Flier, A. W. Lemstra
Additional file 2: Supplementary Table 1. Clinical questionnaires & tests.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40156d8467a9f2258c15ff7dcbd63ab
Autor:
M. Joling, Chris Vriend, Jan Booij, Insa Happach, Ph. Scheltens, Afina W. Lemstra, J J van der Zande
Publikováno v:
NeuroImage: Clinical, 25:102062. Elsevier BV
van der Zande, J J, Joling, M, Happach, I G, Vriend, C, Scheltens, P, Booij, J & Lemstra, A W 2020, ' Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study ', NeuroImage: Clinical, vol. 25, 102062 . https://doi.org/10.1016/j.nicl.2019.102062
NeuroImage. Clinical, 25:102062. Elsevier BV
NeuroImage: Clinical, Vol 25, Iss, Pp-(2020)
Neuroimage. Clinical, 25
van der Zande, J J, Joling, M, Happach, I G, Vriend, C, Scheltens, P, Booij, J & Lemstra, A W 2020, ' Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study ', NeuroImage: Clinical, vol. 25, 102062 . https://doi.org/10.1016/j.nicl.2019.102062
NeuroImage. Clinical, 25:102062. Elsevier BV
NeuroImage: Clinical, Vol 25, Iss, Pp-(2020)
Neuroimage. Clinical, 25
Purpose: To study the influence of concomitant Alzheimer's disease (AD) pathology in dementia with Lewy bodies (DLB) on dopamine transporter (DAT) and serotonin transporter (SERT) availability, using 123I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iod
Autor:
J J, van der Zande, M, Joling, I G, Happach, C, Vriend, Ph, Scheltens, J, Booij, A W, Lemstra
Publikováno v:
NeuroImage : Clinical
Highlights • Dementia with Lewy bodies patients often have Alzheimer's disease co-pathology. • 123I-FP-CIT dopamine transporter binding in pure and mixed DLB seems comparable. • 123I-FP-CIT serotonin transporter binding may be more compromised
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 43(6), 1060-6. Springer Verlag
van der Zande, J J, Booij, J, Scheltens, P, Raijmakers, P G H M & Lemstra, A W 2016, ' [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. 6, pp. 1060-6 . https://doi.org/10.1007/s00259-016-3312-x
European journal of nuclear medicine and molecular imaging, 43(6), 1060-1066. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging
van der Zande, J J, Booij, J, Scheltens, P, Raijmakers, P G H M & Lemstra, A W 2016, ' [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. 6, pp. 1060-6 . https://doi.org/10.1007/s00259-016-3312-x
European journal of nuclear medicine and molecular imaging, 43(6), 1060-1066. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging
PURPOSE: Decreased striatal dopamine transporter (DAT) binding on SPECT imaging is a strong biomarker for the diagnosis of dementia with Lewy bodies (DLB). There is still a lot of uncertainty about patients meeting the clinical criteria for probable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8ab4c12c45783d36c9fc907e1c248d
https://research.vumc.nl/en/publications/9958c8ea-f28f-4371-867e-9206923fbfdf
https://research.vumc.nl/en/publications/9958c8ea-f28f-4371-867e-9206923fbfdf
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: ISHs and ICHs from ruptured MCA aneurysms can be difficult to distinguish on NCE-CT but may have a different impact on admission status and outcome. The presence of IHCEV on CTA may differentiate ISHs and ICHs. MATERIALS AND M
Autor:
Leerssen HM; Department of Cardiology, Cardiovascular Research Institute Maastricht, University Hospital Maastricht, The Netherlands., Vos MA, den Dulk K, van der Zande J, Wellens HJ
Publikováno v:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 1999 Feb; Vol. 22 (2), pp. 291-301.
Autor:
Vos MA; From the Departments of Cardiology, Physiology, Anesthesiology and Pathology, Cardiovascular Research Institute, Maastricht, The Netherlands. m.vos@cardio.azm.nl, de Groot SH, Verduyn SC, van der Zande J, Leunissen HD, Cleutjens JP, van Bilsen M, Daemen MJ, Schreuder JJ, Allessie MA, Wellens HJ
Publikováno v:
Circulation [Circulation] 1998 Sep 15; Vol. 98 (11), pp. 1125-35.
Autor:
Leerssen HM; Department of Cardiology, Cardiovascular Research Institute Maastricht, University Hospital Maastricht, The Netherlands., Vos MA, den Dulk K, van der Zande J, Muijtjens AM, Begemann MJ, Wellens HJ
Publikováno v:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 1998 Sep; Vol. 21 (9), pp. 1766-77.